TOP TIERMARKET NEWSWIRE

News & sentiment

OMEROS CORP (OMER) — News & AI sentiment

OMEROS CORP (OMER) news roundup. 13 stories aggregated over the last 30 days. Average 30-day sentiment is 38.2/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 6 sales totalling $2.2M — net selling of $2.2M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

0

7d stories

0

30d stories

13

avg sentiment 38.2/100

Insider net (90d)

$2.2M

0 buys · 6 sells

Congress (90d)

0

0 buys · 0 sells

OMER news in the last 24 hours, 7 days, 30 days and 90 days

How much OMER coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time window	OMER stories	Avg AI sentiment	Read
Last 24 hours	0	—	no coverage
Last 7 days	0	—	no coverage
Last 30 days	13	38.2/100	OMER headlines →
Last 90 days	40	53/100	OMER headlines →

Latest stories on OMER

Omeros: The Trade After European Rejection

Seeking Alpha42 · neutralanalyst

Oct 21

Omeros Shares Slide After CHMP Upholds Negative Opinion On Drug; Analyst Sees Buying Opportunity At $16

Stocktwits News34 · bearishgeneral

Oct 16

Omeros selloff on CHMP decision overdone, says H.C. Wainwright

The Fly64 · neutralanalyst

Oct 16

Omeros Says European Medicines Agency Upholds Negative Opinion on Narsoplimab Application -- Update

MarketWatch34 · bearishproduct/pr

Oct 16

Omeros Shares Fall 4% as European Regulators Uphold Negative Opinion on Narsoplimab

InvestorsHub34 · bearishgeneral

Oct 16

Omeros Faces Second Rejection Of Narsoplimab In Europe – OMER Stock Falls Below Key Support For First Time In Nearly 3 Months

Stocktwits News34 · bearishgeneral

Oct 16

Why is Omeros stock sliding today?

Investing.com Markets38 · neutralgeneral

Oct 16

Omeros shares slide following European regulatory setback for Narsoplimab

Investing.com Markets34 · bearishgeneral

Oct 16

Omeros faces EU setback as CHMP reiterates negative opinion for narsoplimab in TA-TMA October 16, 2026

MarketChameleon34 · bearishproduct/pr

Oct 16

Omeros transplant therapy snubbed in EU again

Seeking Alpha34 · bearishgeneral

Oct 16

Omeros Says European Medicines Agency Upholds Negative Opinion on Narsoplimab Application

MarketWatch22 · bearishproduct/pr

Oct 16

Omeros Corporation Receives CHMP Negative Opinion Following Re-Examination of European Marketing Authorization Application for Narsoplimab in TA-TMA

StockTitan34 · bearishproduct/pr

Oct 16

Cocaine Use Disorder Market Outlook to Strengthen During the Forecast Period (2026-2036) with Emerging Therapies and Rising Healthcare Needs | DelveInsight

PR Newswire58 · neutralproduct/pr

Oct 14

NTRA Stock Hits All-Time High, OMER Stock Scales 5-Year Peak – What’s Driving Investors’ Enthusiasm Today?

Stocktwits News73 · bullishgeneral

Sep 22

Omeros upgraded at Cantor on Yartemlea opportunity

Business Insider67 · bullishanalyst

Sep 22

Cantor upgrades Omeros on better than expected Yartemlea launch

The Fly63 · neutralanalyst

Sep 22

What Makes Omeros (OMER) a Strong Momentum Stock: Buy Now?

Quartz63 · neutralanalyst

Sep 1

Omeros (OMER) Q2 2026 Earnings Call Transcript

Yahoo Finance50 · neutralearnings

Aug 20

Omeros (OMER) Q2 2026 Earnings Call Transcript

The Motley Fool50 · neutralearnings

Aug 19

Omeros options imply 9.8% move in share price post-earnings

The Fly56 · neutralearnings

Aug 17

Omeros reports Q2 adjusted EPS 2c vs (24c) last year

The Fly58 · neutralearnings

Aug 17

Omeros: YARTEMLEA Is Off To A Blistering Start

Seeking Alpha73 · bullishproduct/pr

Aug 14

Omeros Appoints Veteran Investor Joseph Schocken to Board

TipRanks55 · neutralgeneral

Aug 13

OMEROS CORP (OMER) files 8-K

SEC 8-K50 · neutralgeneral

Aug 13

Top trending stocks today: ARX, OMER, TMS lead the market movers

Investing.com Markets50 · neutralgeneral

Aug 13

Open OMER in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →